BellaSeno GmbH is a clinical-stage regenerative medicine company developing next-generation bioresorbable scaffold technologies for soft-tissue and structural tissue applications. The company’s proprietary platform combines well-known biomaterials, high-throughput additive manufacturing and advanced proprietary scaffold design to support the body’s own tissue formation over time. BellaSeno is headquartered in Leipzig, Germany, with clinical and development activities in Europe and Australia.
Looking for a particular BellaSeno employee's phone or email?
BellaSeno Questions
The BellaSeno annual revenue was $6 million in 2026.
Thomas Lingner is the CTO of BellaSeno.
16 people are employed at BellaSeno.
BellaSeno is based in Leipzig, Saxony.
The NAICS codes for BellaSeno are [541, 541713, 5417, 54171, 54].
The SIC codes for BellaSeno are [873, 87].
Top BellaSeno Employees
-
Thomas Lingner
Chief Technology Officer at BellaSeno
Göttingen, NDS, DE1 -
Sara Lucarotti
Head of Clinical Operations at BellaSeno
Viareggio, IT1 -
Patrick Haubruck
Vice President R and D at BellaSeno
Artarmon, NSW, AU3 -
Laura Salucci
Head Of Design Department at BellaSeno
Leipzig, SN, DE1 -
Alexander Schneider
Head Of Automation at BellaSeno
Leipzig, SN, DE1 -
Giuseppe Strumbo
Design Engineer at BellaSeno
Leipzig, SN, DE1 -
Mathias Falkenberg
Director of Manufacturing at BellaSeno
Leipzig, SN, DE1
Related Companies
